在Zollinger-Ellison综合征中尿液的作用
Lancet (London, England)
|September 6, 1975
概括
人类泌尿素有效地治疗佐林格-埃里森综合征 (ZES). 这项研究表明,urogastrone可以降低ZES患者的胃酸和疼痛,为酸过分分泌的疾病提供一种潜在的治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 佐林格-埃里森综合征 (ZES) 的特征是胃酸分泌过多.
- 在ZES中的酸过分分泌会导致严重的胃肠道问题,包括和疼痛.
- 目前的治疗方法旨在控制酸度,但不断寻找新的治疗药物.
研究的目的:
- 为了研究人类泌尿胃素对胃酸分泌和相关参数在Zollinger-Ellison综合征患者的影响.
- 评估尿胃素对胃酸体积,度,内在因子,素和血胃素水平的影响.
- 评估urogastrone在缓解与ZES相关的疼痛方面的治疗潜力.
主要方法:
- 对四名被诊断为ZES的男性患者和四名健康对照人进行静脉注射人体泌尿 (0-25毫克/千克/小时).
- 在输注泌尿胃素之前和期间测量胃酸体积,度,内在因子,素和血胃素水平.
- 血胃素度变化与胃酸输出减少之间的相关性分析.
主要成果:
- 在ZES患者中,泌尿显著降低了胃酸体积和度,使基酸输出减少了50-82%.
- 胃汁内在因子和素的度在输注尿液中增加了60-300%.
- 血胃素度的峰值增加了127-164%,在增加的胃素和减少的酸输出之间观察到显著的负相关性 (r=-0.72,P<0.01).
- 报告说,在开始输注泌尿胃素后的30-60分钟内,的疼痛得到缓解.
结论:
- 人类泌尿胃素在Zollinger-Ellison综合征中表现出强烈抑制内源刺激的酸过分分泌.
- 乌罗加可能为管理ZES和相关的酸过分分泌障碍提供一种新的治疗策略.
- 观察到的血胃素的增加表明复杂的反机制或泌尿胃素对胃素释放的直接影响.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...


